tradingkey.logo

BRIEF-Alpha Cognition Secures Additional U.S. Patent For Zunveyl (Benzgalantamine)

ReutersFeb 12, 2025 1:35 PM

- Alpha Cognition ACOG.O:

  • ALPHA COGNITION SECURES ADDITIONAL U.S. PATENT FOR ZUNVEYL (BENZGALANTAMINE) IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER’S DISEASE

Source text: ID:nBw5Qvjy1a

Further company coverage: ACOG.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI